FENC Q4 2021 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$220M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.17

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$910,000

Balance Sheet

Total Assets

$22M

Total Liabilities

$7M

Stockholders' Equity

$16M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$170,000	-100.0%
Gross Profit	$0	$170,000	-100.0%
Operating Income	-$4M	-$3M	-25.3%
Net Income	-$4M	-$3M	-36.3%